Primary completion· ClinicalTrials.gov
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
buntanetap/posiphen History and Updates
14 events · 2022 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
14
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-04Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for buntanetap/posiphen since 2022, drawn from openFDA, ClinicalTrials.gov, and PubMed.
All published updates (2)
2025
- Results postedBuntanetap 15mg Shows Greater ADAS-Cog11 Improvement in Alzheimer's Trial· Apr 29, 2025
- Results postedBuntanetap/Posiphen Improves MMSE in Early Parkinson's Subgroup· Mar 3, 2025
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
A Study of Buntanetap in Participants With PD
Past events
2026
Trial started· ClinicalTrials.gov
A Study of Buntanetap in Participants With PD
2025
Trial registered· ClinicalTrials.gov
A Study of Buntanetap in Participants With PD
Results posted· ClinicalTrials.gov
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Results posted· ClinicalTrials.gov
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Trial started· ClinicalTrials.gov
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
2024
Trial registered· ClinicalTrials.gov
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Primary completion· ClinicalTrials.gov
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
2023
Primary completion· ClinicalTrials.gov
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Trial started· ClinicalTrials.gov
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Trial registered· ClinicalTrials.gov
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
2022
Trial started· ClinicalTrials.gov
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Trial registered· ClinicalTrials.gov
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.